Medika Natura’s proprietary product SKF7™ is the first native Malaysian ingredient to be officially listed on Regulations.gov
Medika Natura’s proprietary product SKF7™ is the first native Malaysian ingredient to be listed on the Regulations.gov website and the first native Malaysian product to be authorised as a new dietary ingredient (NDIN) by the United States FDA (US FDA).
SKF7™ is currently undergoing Phase 2 clinical trials in general hospitals and clinics across Malaysia and Indonesia. This same study has just been completed in India.
Another unprecedented effort by Medika Natura, this multinational, multicenter trial is the first of its kind for all three countries. The trials are conducted to determine the efficacy of SKF7™ in curtailing obesity to enable it to be classified and marketed as an anti-obesity botanical drug.
Regulations.gov is a U.S. federal government website internet portal and document repository that allows members of the public to find, read, and comment on the rule-making processes of participating government agencies.